GlassScriptPhysician profile
Jennifer M Rogers
NPI 1770924391
$9,452.63
in general payments reported to CMS, 2019-2025
45 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,619 · 2022: $1,594 · 2023: $1,849 · 2024: $1,664 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,140 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,139.62 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,856.23 | 2021-2023 | Xiaflex |
| Astellas Pharma US INC | $613.91 | 2021-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $610.88 | 2021-2025 | |
| Endo USA, INC. | $539.40 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $459.47 | 2021-2024 | Gentlecath, Gentlecath Glide, Cure Ultra Catheter |
| Dendreon Pharmaceuticals LLC | $457.47 | 2021-2025 | Provenge |
| Antares Pharma, INC. | $457.36 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Abbvie INC. | $431.88 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $351.64 | 2022-2025 | Lynparza, Keytruda |
| Urovant Sciences INC | $271.66 | 2021-2022 | |
| Janssen Biotech, INC. | $241.55 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Alnylam Pharmaceuticals INC. | $203.92 | 2021-2025 | Givlaari |
| Myriad Genetic Laboratories, INC. | $194.61 | 2021-2024 | Prolaris |
| Urogen Pharma, INC. | $194.54 | 2022-2024 | Jelmyto |
| Axonics, INC. | $187.83 | 2021-2024 | Bulkamid, Axonics |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.